Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population
PD is a complex disease, and may result from gene–gene and gene–environment interactions. There are limited studies on gene–gene interactions in PD. We and others have previously shown that SNCA rs356219, LRRK2 (rs2046932 and rs7304279) and GAK (rs1564282) are risk factors in sporadic PD. Since the...
Main Authors: | Wen-Juan Yu, Lan Cheng, Nan-Nan Li, Ling Wang, Eng-King Tan, Rong Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | eNeurologicalSci |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650215000039 |
Similar Items
-
The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation
by: Jun Egawa, et al.
Published: (2022-07-01) -
Novel Therapeutic Horizons: <i>SNCA</i> Targeting in Parkinson’s Disease
by: Alessio Maria Caramiello, et al.
Published: (2024-08-01) -
LRRK2 G2019S, I2020T, R1441C GENE mutation analysis in patients with idiopathic Parkinsons in Turkey
by: Ahmet Adiguzel, et al.
Published: (2020-06-01) -
Genetics of Parkinson's disease: Dominant forms and GBA
by: P. Salles, MD, et al.
Published: (2024-07-01) -
Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
by: Yihang Han, et al.
Published: (2022-06-01)